Clinical Trial: Prospective, Multicenter, Open-label, Randomized, Parallel Groups Clinical Study to Compare Efficacy and Safety of Indinol Forto(R) 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164183) titled 'Prospective, Multicenter, Open-label, Randomized, Parallel Groups Clinical Study to Compare Efficacy and Safety of Indinol Forto(R) 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis' on Sept. 02.

Brief Summary: Prospective open-label randomized parallel groups study to compare efficacy and safety of Indinol Forto(R) 200 mg capsules and Visanne 2 mg tablets in treatment of endometriosis. This is phase 3 study, based on hypothesis of non-inferiority.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Endometriosis

Intervention: DRUG: Indole-3-carbinol

Indinol Forto (indolecarbinol (indole-...